|
SVRA | Savara Inc |
|
|
SVRA | Savara Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.11 |
| Leverage | 33.02% |
| Market Cap | $ 870.3m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -115.3m |
| Margin | -2039.77% |
Savara Inc. is a lung disease orphan company. The company is headquartered in Austin, Texas.